Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mingkai Gong
Institution:
Affiliated Hospital of Qingdao University
Observed institution:
Affiliated Hospital of Qingdao University
ORCID:
0000-0001-5685-8530
Observed ORCID:
0000-0001-5685-8530
OpenAlex ID:
A5050794573
Identification of a Lipid Metabolism-Associated Gene Signature Predicting Survival in Breast Cancer
2021
·
Mingkai Gong
, Xiangping Liu
, et al.
·
International Journal of General Medicine
·
25
PDF
Alpinetin suppresses CYP3A4, 2C9, and 2E1 activity in vitro
2022
·
Hongming Song
, Chuankui Wei
, et al.
·
Pharmaceutical Biology
·
11
Integrated Analysis of Bulk RNA Sequencing, eQTL , GWAS , and Single‐Cell RNA Sequencing Reveals Key Genes in Hepatocellular Carcinoma
2025
·
Mingkai Gong
, Xian Zhao
, et al.
·
Journal of Cellular and Molecular Medicine
·
8
A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation
2022
·
Mingkai Gong
, Xiangping Liu
, et al.
·
BMC Cancer
·
8
PDF
Augmentation of antitumor function of tumor‐infiltrating lymphocytes against triple‐negative breast cancer by PD‐1 blockade
2021
·
Hongming Song
, Haibo Wang
, et al.
·
Cell Biology International
·
8
PDF
FOXC1–GMDS axis-driven glycolytic reprogramming promotes tumor progression in triple-negative breast cancer
2026
·
Mingkai Gong
, Meijuan Gong
, et al.
·
Cell Death and Disease
PDF
UBR5-KDM5A axis rewires redox metabolism to confer cisplatin resistance in triple-negative breast cancer via the cAMP-PKA-SIRT3 cascade
2026
·
Mingkai Gong
, Fan Liang
, et al.
·
Drug Resistance Updates
Regulation of Cell Function and Myeloid‐Derived Suppressor Cell Chemotaxis by hsa_circ_0006466‐miR‐1286‐ PDGFRA / B Axis in Triple Negative Breast Cancer
2026
·
Fengqin Gao
, Mingkai Gong
, et al.
·
Analytical Cellular Pathology
Show more works
View as search
Works count:
8
Citation count:
60
H-index:
5
I10-index:
2
Year
Topic
Type